Post-bronchodilator Spirometry Reference Values in Adults and Implications for Disease Management
Overview
Affiliations
Rationale: International guidelines promote the use of post-bronchodilator spirometry values in the definition and severity classification of chronic obstructive pulmonary disease. However, post-bronchodilator reference values have not yet been developed.
Objectives: To derive reference values for post-bronchodilator forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and FEV1/FVC, and to compare these reference values with locally derived and existing pre-bronchodilator reference values.
Methods: Based on a random sample of a general adult population, 2,235 subjects (70% of invited subjects) performed spirometry with reversibility testing. A reference population of healthy never-smokers constituted 23% of the study population (n=515). Reference values for median and lower-limit-of-normal pre- and post-bronchodilator lung function and bronchodilator response were modeled using quantile regression analyses.
Main Results: The reference population had equal proportions of men and women in the age range 26-82 yr. Both FEV1 and FVC decreased with age and increased with height. FEV1/FVC decreased with age, although this trend was not statistically significant for men after bronchodilatation. Linear models gave the best overall fit. Lower-limit-of-normal post-bronchodilator FEV1/FVC exceeded 0.7 for both sexes. Post-bronchodilator prediction equations gave higher predicted FEV1 and FEV1/FVC than both locally derived and existing pre-bronchodilator equations. The bronchodilator response decreased with age.
Conclusions: The present study is the first to develop reference values for post-bronchodilator lung function. Post-bronchodilator prediction equations can facilitate better management of patients with chronic obstructive pulmonary disease by avoiding falsely high FEV1% predicted with a subsequent underestimation of disease severity.
Singh D, Stockley R, Anzueto A, Agusti A, Bourbeau J, Celli B Eur Respir J. 2024; 65(2).
PMID: 39638416 PMC: 11799884. DOI: 10.1183/13993003.01603-2024.
Malinovschi A, Johannessen A Am J Respir Crit Care Med. 2024; 210(7):857-859.
PMID: 39093573 PMC: 11506898. DOI: 10.1164/rccm.202406-1212ED.
Chen K, Hung M, Kao K Heliyon. 2024; 10(1):e23627.
PMID: 38187302 PMC: 10767126. DOI: 10.1016/j.heliyon.2023.e23627.
Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness.
Beasley R, Hughes R, Agusti A, Calverley P, Chipps B, Del Olmo R Am J Respir Crit Care Med. 2023; 209(4):390-401.
PMID: 38029294 PMC: 10878375. DOI: 10.1164/rccm.202308-1436OC.
Postbronchodilator Reference Values: Should They Be the Norm?.
Smith L Am J Respir Crit Care Med. 2023; 208(4):356-357.
PMID: 37478330 PMC: 10449071. DOI: 10.1164/rccm.202306-1082ED.